Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxocobalamin vs Methylene Blue for Vasoplegic Syndrome in Liver Transplant
NCT04054999Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- Nov 2019
- Primary completion
- Feb 2023
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of hydroxocobalamin in vasoplegic syndrome (VPS), sponsored by Mayo Clinic. Started Nov 2019; status: completed.
02
Drugs
hydroxocobalamin
03
Conditions
vasoplegic syndrome (VPS)
Beyond the preview
Go deeper on NCT04054999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04054999.